The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockers
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 20 (1)
Abstract
Objective: In our recent study, non-Gaussianity of heart rate variability (λ25s), an indicator of sympathetic nerve activity, did not change during two-day treatment with the angiotensin II type 1 receptor blocker (ARB) azilsartan. Coadministration of calcium channel blockers (CCBs) might affect the study results. Methods: In this subanalysis, 20 patients with chronic kidney disease (14 men; age 61±15 years) were divided into three groups: patients with coadministration of L-type CCB, patients without coadministration of CCB, and patients with coadministration of sympathoinhibitory (L/T- or L/T/N-type) CCB. λ25s was calculated separately in daytime and nighttime. Results: Daytime λ25s at baseline was higher in patients with L-type CCB coadministration (0.62±0.18, n = 5) compared with those without CCB (0.49±0.13, n = 11) and those with sympathoinhibitory CCB (0.46±0.06, n = 4). The relationship between the changes in daytime λ25s and systolic blood pressure was positive in patients with L-type CCB coadministration, whereas the relationship was inverse in the other two groups. A larger decrease in daytime λ25s was shown in patients with L-type CCB coadministration compared with those in the other two groups. Conclusions: CCBs, as well as diuretics, are recommended as second-line antihypertensive agents. Our results suggested that ARBs can overwhelm the activation of sympathetic nerve activity stimulated by coadministration of L-type CCBs.Keywords
This publication has 22 references indexed in Scilit:
- Changes in muscle sympathetic nerve activity and vascular responses evoked in the spinotrapezius muscle of the rat by systemic hypoxiaThe Journal of Physiology, 2011
- Increased Non-Gaussianity of Heart Rate Variability Predicts Cardiac Mortality after an Acute Myocardial InfarctionFrontiers in Physiology, 2011
- Intensive Blood-Pressure Control in Hypertensive Chronic Kidney DiseaseNew England Journal of Medicine, 2010
- Azelnidipine Decreases Sympathetic Nerve Activity Via Antioxidant Effect in the Rostral Ventrolateral Medulla of Stroke-prone Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 2008
- Non-Gaussian heart rate as an independent predictor of mortality in patients with chronic heart failureHeart Rhythm, 2008
- Effects of a New Calcium Channel Blocker, Azelnidipine, on Systemic Hemodynamics and Renal Sympathetic Nerve Activity in Spontaneously Hypertensive RatsHypertension Research, 2005
- Fractal Correlation Properties of R-R Interval Dynamics and Mortality in Patients With Depressed Left Ventricular Function After an Acute Myocardial InfarctionCirculation, 2000
- Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failureKidney International, 1997
- Heart Rate VariabilityCirculation, 1996
- The differential effects of prazosin and hydralazine on sympathoadrenal activity in conscious ratsEuropean Journal of Pharmacology, 1989